Other diseases of spinal cord

G6_SPINOTH

spinal cord disease: A disease involving the spinal cord.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — G95 Hospital discharge: ICD-9 — 336 Hospital discharge: ICD-8 — 349 Cause of death: ICD-10 — G95 Cause of death: ICD-9 — 336 Cause of death: ICD-8 — 349 2 out of 7 registries used, show all original rules.	1122
4. Check minimum number of events None	1122
5. Include endpoints None	1122
6. Filter based on genotype QC (FinnGen only)	1122

Control definitions (FinnGen only)

Control exclude: G6_OTHNEU

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: G90-G99

NAME	G6_SPINOTH
CONTROL_EXCLUDE	G6_OTHNEU
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	G95
HD_ICD_9	336
HD_ICD_8	349
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	G95
COD_ICD_9	336
COD_ICD_8	349
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other diseases of spinal cord based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Other specified diseases of spinal cord, drug-induced

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	9073	4166	4815
Only index persons	7450	3565	3885
Unadjusted period prevalence (%)
Whole population	0.13	0.12	0.13
Only index persons	0.14	0.13	0.15
Median age at first event (years)
Whole population	53.28	52.68	53.64
Only index persons	51.72	51.16	52.23

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	1122	570	552
Unadjusted period prevalence (%)	0.22	0.19	0.24
Median age at first event (years)	52.44	48.84	56.16

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
1009: Matched controls
10088

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

G95.8

ICD-10 Finland

Other specified diseases of spinal cord

+∞

323.0

371

G95.0

ICD-10 Finland

Syringomyelia and syringobulbia

3334.3

287.6

264

XKC03

NOMESCO Finland

Water cystometry

32.4

200.4

269

112

G95.9

ICD-10 Finland

Disease of spinal cord, unspecified

+∞

181.9

169

M03BX01

ATC

baclofen; systemic

50.2

156.6

189

T91.3

ICD-10 Finland

Sequelae of injury of spinal cord

573.6

153.0

148

XKD06

NOMESCO Finland

Physiologic investigation of micturition

23.2

150.8

223

122

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

12.3

133.3

258

273

G82.2

ICD-10 Finland

Paraplegia, unspecified

174.2

105.5

109

N03AX16

ATC

pregabalin; oral

4.9

103.0

430

1321

N03AX12

ATC

gabapentin; oral

5.8

101.4

337

797

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

11.8

96.2

187

191

XKD03

NOMESCO Finland

Urethral pressure profilometry

21.5

93.3

140

G95.2

ICD-10 Finland

Cord compression, unspecified

+∞

92.1

UKC02

NOMESCO Finland

Cystoscopy

5.2

91.0

341

909

N31.9

ICD-10 Finland

Neuromuscular dysfunction of bladder, unspecified

71.5

90.5

103

N18

ICPC

Paralysis/weakness

29.3

89.5

122

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

43.9

88.9

110

L89

ICD-10 Finland

Decubitus ulcer and pressure area

30.2

87.3

118

G95.1

ICD-10 Finland

Vascular myelopathies

+∞

86.7

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

38.5

79.4

101

TKC20

NOMESCO Finland

Catheterisation of bladder

7.5

77.6

199

321

N31.2

ICD-10 Finland

Flaccid neuropathic bladder, not elsewhere classified

37.7

77.5

J01EA01

ATC

trimethoprim; systemic

3.9

75.8

402

1455

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

7.4

74.6

192

310

R1250

NOMESCO Finland

Evaluation of functional capability

20.4

74.3

113

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

17.0

70.2

114

G35

ICD-10 Finland

Multiple sclerosis

22.8

67.7

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

4.8

67.4

260

685

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

19.6

67.0

103

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

11.4

66.8

130

129

N31.1

ICD-10 Finland

Reflex neuropathic bladder, not elsewhere classified

64.0

66.6

SPAT1229

SPAT

Assessment of need for aid

6.7

65.7

182

323

KCV12

NOMESCO Finland

Urinary bladder endoscopic botulin therapy

39.5

61.0

SPAT1262

SPAT

Handing over of treatment supplies

3.7

57.6

307

1069

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

4.3

57.6

243

688

R33

ICD-10 Finland

Retention of urine

5.7

57.4

179

366

N31.8

ICD-10 Finland

Other neuromuscular dysfunction of bladder

73.2

54.8

S14.0

ICD-10 Finland

Concussion and oedema of cervical spinal cord

189.9

52.4

N03AE01

ATC

clonazepam; systemic

6.6

51.9

143

248

109

Kela drug reimbursment

Multiple sclerosis

24.1

51.8

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

3.9

50.5

236

725

G82.1

ICD-10 Finland

Spastic paraplegia

+∞

50.4

J01MA02

ATC

ciprofloxacin; systemic

2.8

50.1

498

2622

NA2CG

NOMESCO Finland

Thoracal spine extensive MRI examination with high intensity magnet

25.8

50.0

G04BD12

ATC

mirabegron; oral

4.8

50.0

184

449

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

4.3

49.8

205

560

L28

ICPC

Limited function/disability (L)

3.8

48.9

244

790

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

29.9

46.2

303

Kela drug reimbursment

Dimethyl fumarate, interferon beta, glatiramer acetate and teriflunomid (Multiple sclerosis)

27.9

46.1

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

5.3

45.9

151

324

WX408

NOMESCO Finland

General anesthesy, balanced

2.9

45.8

372

1704

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

4.5

45.8

179

462

G04BD08

ATC

solifenacin; oral

5.6

45.4

141

283

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

3.5

45.3

245

842

34999

ICD-8 Finland

Other diseases of spinal cord, Other and unspecified

+∞

45.1

AA1AD

NOMESCO Finland

CT of head and brain

3.2

44.7

292

1151

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

3.4

44.1

249

882

A28

ICPC

Limited function/disability NOS

3.7

44.1

218

695

R4120

NOMESCO Finland

Occupational therapy

5.8

43.4

131

253

N31.0

ICD-10 Finland

Uninhibited neuropathic bladder, not elsewhere classified

156.8

43.1

N30.0

ICD-10 Finland

Acute cystitis

3.7

42.8

212

675

N06AX21

ATC

duloxetine; oral

4.2

42.7

179

492

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

9.7

42.2

XKD00

NOMESCO Finland

Uroflowmetry

3.2

41.6

256

961

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

5.5

40.8

128

259

KA1AE

NOMESCO Finland

Kidney ultrasound examination

9.7

39.9

S24.0

ICD-10 Finland

Concussion and oedema of thoracic spinal cord

+∞

39.8

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

11.3

39.2

G82.5

ICD-10 Finland

Tetraplegia, unspecified

89.8

39.1

Q07.0

ICD-10 Finland

Arnold-Chiari syndrome

109.4

39.0

SPAT1148

SPAT

Treatment of chronic ulcer or burn

3.5

39.0

209

702

M48.0

ICD-10 Finland

Spinal stenosis

3.7

38.4

185

571

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

4.2

37.8

157

425

ABC60

NOMESCO Finland

Decompression of cervical spinal cord

35.9

37.5

G99.2*M47.1

ICD-10 Finland

Spondylogenic compression of spinal cord

380.7

37.3

T91.1

ICD-10 Finland

Sequelae of fracture of spine

104.0

37.0

S97

ICPC

Chronic ulcer skin

5.6

37.0

114

225

N86

ICPC

Multiple sclerosis

31.4

36.4

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

4.6

36.2

133

319

N32.83

ICD-10 Finland

Nozzle synergy in the bladder neck

101.3

36.0

NA7BG

NOMESCO Finland

Spine and spinal cord MRI examination with high intensity magnet

39.2

35.9

N32.82

ICD-10 Finland

Instability of the detrusor vesicae muscle

13.7

35.5

ZXE20

NOMESCO Finland

More than three and less than five hours

3.3

35.5

209

750

A06AD11

ATC

lactulose; oral

3.3

35.5

203

712

ZXD05

NOMESCO Finland

Urgent procedure

2.5

35.2

386

2031

157

Kela drug reimbursment

Dimethyl fumarate, glatiramer acetate, interferon beta and teriflunomid (Multiple sclerosis)

21.0

35.1

N28

ICPC

Limited function/disability (N)

16.4

34.6

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

7.2

34.6

131

N81

ICPC

Injury nervous system other

59.4

34.4

G99.2

ICD-10 Finland

Myelopathy in diseases classified elsewhere

+∞

33.5

G04BD07

ATC

tolterodine; oral

5.9

33.5

181

S22.0

ICD-10 Finland

Fracture of thoracic vertebra

12.7

33.3

N99

ICPC

Neurological disease other

18.1

32.2

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

3.3

31.9

182

636

M03BX02

ATC

tizanidine; oral

2.2

31.9

656

4584

L03AB07

ATC

interferon beta-1a; parenteral

28.0

31.7

N02AA05

ATC

oxycodone; systemic

3.1

31.5

197

734

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

4.2

30.7

126

335

M49.4*G95.0

ICD-10 Finland

Neuropathic spondylopathy in syringomyelia and syringobulbia

+∞

30.4

S12.2

ICD-10 Finland

Fracture of other specified cervical vertebra

18.2

30.3

SPAT1167

SPAT

Insertion of urinary catheter

7.1

30.3

114

G04BD04

ATC

oxybutynin; oral, transdermal

5.0

30.0

102

224

SPAT1215

SPAT

Assessment of need for medical rehabilitation

6.0

30.0

155

G82.0

ICD-10 Finland

Flaccid paraplegia

311.2

30.0

U05

ICPC

Urination problems other

5.6

29.9

176

NAJ22

NOMESCO Finland

Posterior reduction of fractrue of thoracic spine

85.3

29.9

N02AX02

ATC

tramadol; systemic, rectal

2.2

29.4

470

2893

J01CA08

ATC

pivmecillinam; oral

2.2

29.0

415

2425

TKC10

NOMESCO Finland

Percutaneous puncture of bladder

11.1

28.8

TKC22

NOMESCO Finland

Catheterisation instruction

8.5

28.7

SPAT1231

SPAT

Assessment of adjustments needed in living environment

10.5

28.5

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.3

28.4

340

1821

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

5.9

28.2

150

J01MA12

ATC

levofloxacin; systemic

2.6

27.9

247

1129

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

2.9

27.9

195

775

TPH04

NOMESCO Finland

Cathetrisation of vein

2.5

27.5

259

1228

SPAT1301

SPAT

No procedures

2.2

27.5

361

2015

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.8

27.2

202

836

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

5.6

27.0

154

U07

ICPC

Urine symptom/complaint other

4.4

26.6

101

248

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

+∞

26.2

L03AX13

ATC

glatiramer acetate; parenteral

31.9

26.0

TAB00

NOMESCO Finland

Lumbar puncture

5.4

26.0

161

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

3.5

26.0

129

402

R4110

NOMESCO Finland

Physiotherapy

2.3

25.9

301

1578

QBG10

NOMESCO Finland

Excision and repair of bedsore of trunk

95.9

25.8

M47.1

ICD-10 Finland

Other spondylosis with myelopathy

13.9

25.7

R20.2

ICD-10 Finland

Paraesthesia of skin

4.0

25.4

106

285

3369X

ICD-9 Finland

Other diseases of spinal cord, Unspecified disease of spinal cord

+∞

25.1

J01XE01

ATC

nitrofurantoin; oral

8.8

24.6

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.2

24.3

326

1818

SPAT1263

SPAT

Sampling

2.0

24.2

451

2884

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

6.4

24.0

105

U13

ICPC

Bladder symptom/complaint other

6.1

23.9

117

TPH07

NOMESCO Finland

Cathetrisation of artery

3.1

23.9

144

517

ABE50

NOMESCO Finland

Occipitocervical decompression

128.0

23.7

N30.9

ICD-10 Finland

Cystitis, unspecified

4.4

23.2

211

NA1AD

NOMESCO Finland

Cervical spine CT examination

5.3

23.2

143

X59

ICD-10 Finland

Exposure to unspecified factor

2.4

23.1

223

1057

ABB20

NOMESCO Finland

Drainage of intra- or extramedullary cyst of spinal canal

+∞

23.0

9072A

ICD-9 Finland

Late effects of injuries to the nervous system, Late effect of spinal cord injury

+∞

23.0

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

4.0

22.9

264

K59.09

ICD-10 Finland

Constipation, unspecified

4.0

22.8

260

G99.2*M47.9

ICD-10 Finland

Myelopathy in spondylosis

235.0

22.7

ABD40

NOMESCO Finland

Implantation of spinal injection device

235.0

22.7

WX402

NOMESCO Finland

General anaesthesia

2.5

22.5

203

926

ABB00

NOMESCO Finland

Excision of lesion of spinal canal

46.1

22.4

K59.0

ICD-10 Finland

Constipation

4.0

22.2

246

W17

ICD-10 Finland

Other fall from one level to another

4.6

22.1

183

J01XX05

ATC

methenamine; oral

16.4

22.0

WX704

NOMESCO Finland

Intubation

3.5

22.0

110

344

G99.2*M50.0

ICD-10 Finland

Cervical disc disorder with myelopathy

+∞

21.9

J01MA06

ATC

norfloxacin; oral

2.7

21.8

170

714

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

9.7

21.7

W19

ICD-10 Finland

Unspecified fall

3.1

21.6

128

453

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

5.5

21.5

125

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

7.5

21.5

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

12.3

21.2

U04

ICPC

Incontinence urine

4.6

21.1

177

G04AC01

ATC

6.0

21.1

103

204

Kela drug reimbursment

Leukemia lymphatica

5.4

21.1

128

R15

ICD-10 Finland

Faecal incontinence

6.4

21.0

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.9

20.9

139

530

N06AX16

ATC

venlafaxine; oral

2.6

20.6

166

708

NA7EA

NOMESCO Finland

Scoliosis X-ray examination

14.0

20.1

SPAT1216

SPAT

Assessment of functional ability

2.5

19.7

170

755

U29

ICPC

Urinary symptom/complaint other

5.6

19.6

109

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.5

19.6

169

751

N06AA09

ATC

amitriptyline; systemic

2.9

19.5

128

483

N03AX09

ATC

lamotrigine; oral

4.3

19.3

184

N02BE01

ATC

paracetamol; systemic, rectal

2.2

19.2

853

7238

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

3.2

19.1

104

346

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

20.5

19.1

G83.4

ICD-10 Finland

Cauda equina syndrome

20.5

19.1

KCW98

NOMESCO Finland

Other transluminal endoscopic operation on bladder

56.1

19.0

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.7

19.0

145

600

AAF05

NOMESCO Finland

Ventriculoperitoneal shunt

+∞

18.8

G04BE03

ATC

sildenafil; oral

8.8

18.8

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

193.4

18.6

G04CA02

ATC

tamsulosin; oral

2.1

18.5

249

1360

M47.9

ICD-10 Finland

Spondylosis, unspecified

5.6

18.5

100

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

4.1

18.4

187

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.5

18.4

160

712

H01BA02

ATC

desmopressin; nasal, systemic, sublingual

8.5

18.3

ABD32

NOMESCO Finland

Implantation of temporary spinal stimulation device

25.6

18.3

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

6.6

18.3

R39.1

ICD-10 Finland

Other difficulties with micturition

5.1

18.2

119

QBG00

NOMESCO Finland

Debridement of bedsore of trunk

53.5

18.0

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.7

18.0

134

547

R51.80

ICD-10 Finland

Headache

2.5

17.9

156

695

308

Kela drug reimbursment

Alprostadil, sildenafil and combination product containing aviptadil and phentolamine

6.8

17.8

S14.1

ICD-10 Finland

Other and unspecified injuries of cervical spinal cord

+∞

17.8

34998

ICD-8 Finland

Other diseases of spinal cord, Alii definiti

+∞

17.8

3360A

ICD-9 Finland

Other diseases of spinal cord, Syringomyelia and syringobulbia

+∞

17.8

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.7

17.8

132

537

Z01.8

ICD-10 Finland

Other specified special examinations

2.1

17.6

232

1253

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

6.3

17.6

H46

ICD-10 Finland

Optic neuritis

14.2

17.3

NAJ32

NOMESCO Finland

Posterior reduction of fractrue of lumbar spine

42.8

17.3

Z3226

NOMESCO Finland

Physiotherapist

2.2

17.3

206

1067

N05BA01

ATC

diazepam; systemic, rectal

2.4

17.3

153

687

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

2.4

17.3

162

748

WX725

NOMESCO Finland

Noninvasive ventilation

4.0

17.2

189

NA1CM

NOMESCO Finland

Cervical spine extensive MRI examination with 3 Tesla magnet

50.9

17.0

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

3.7

17.0

212

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.1

17.0

328

ZXE10

NOMESCO Finland

More than one and less than three hours

1.8

16.9

370

2414

G04BD09

ATC

trospium; oral

6.0

16.8

Z3229

NOMESCO Finland

Other healthcare associate professional

2.9

16.7

108

403

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

7.0

16.6

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

4.0

16.6

180

N04BB01

ATC

amantadine; oral

7.7

16.5

N39.4

ICD-10 Finland

Other specified urinary incontinence

3.1

16.5

329

L86

ICPC

Back syndrome with radiating pain

3.5

16.4

234

TQW11

NOMESCO Finland

Vacuum treatment of wound

7.0

16.3

JN5BD

NOMESCO Finland

Head and body CT examination for trauma

15.7

16.2

R52.2

ICD-10 Finland

Other chronic pain

4.9

15.9

110

Z3231

NOMESCO Finland

Registered nurse

1.9

15.9

285

1729

NAJ10

NOMESCO Finland

Anterior reduction of fracture of cervical spine

61.0

15.8

NAG53

NOMESCO Finland

Posterior or lateral fusion of thoracic spine with fixation, more than 3 vertebraea

61.0

15.8

NA1DG

NOMESCO Finland

Cervical spine very extensive MRI examination with high intensity magnet

34.0

15.8

A06AC01

ATC

ispaghula (psylla seeds); oral

2.0

15.7

246

1419

G45.0

ICD-10 Finland

Vertebro-basilar artery syndrome

+∞

15.7

Z43.5

ICD-10 Finland

Attention to cystostomy

19.6

15.6

G37.9

ICD-10 Finland

Demyelinating disease of central nervous system, unspecified

14.0

15.6

G82.4

ICD-10 Finland

Spastic tetraplegia

162.4

15.5

SPAT1260

SPAT

Consultation of another employee

2.1

15.5

199

1059

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

3.6

15.5

202

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.0

15.4

217

1200

L03AB08

ATC

interferon beta-1b; parenteral

38.7

15.4

R31

ICD-10 Finland

Unspecified haematuria

2.6

15.4

115

469

N12

ICD-10 Finland

Tubulo-interstitial nephritis, not specified as acute or chronic

7.7

15.3

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.8

15.2

348

2289

V49.9

ICD-10 Finland

Car occupant [any] injured in unspecified traffic accident

4.2

15.1

145

M54.1

ICD-10 Finland

Radiculopathy

4.2

14.9

142

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

8.1

14.9

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

2.8

14.9

370

AWB00

NOMESCO Finland

Reoperation for superficial infection in surgery of the nervous system

57.5

14.8

ABB10

NOMESCO Finland

Resection of lesion of spinal canal

57.5

14.8

N05CF01

ATC

zopiclone; oral

1.8

14.7

318

2046

J01FF01

ATC

clindamycin; systemic

1.9

14.7

275

1687

L17

ICPC

Foot/toe symptom/complaint

1.9

14.7

261

1573

M54.4

ICD-10 Finland

Lumbago with sciatica

2.1

14.6

173

887

C03CA01

ATC

furosemide; systemic

1.9

14.6

268

1632

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

5.8

14.3

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.8

14.3

379

D32.1

ICD-10 Finland

Benign neoplasm: Spinal meninges

43.1

14.1

G04AA01

ATC

12.2

14.1

U71

ICPC

Cystitis/urinary infection other

3.2

14.1

246

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

4.5

14.1

116

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.9

14.1

310

M54.5

ICD-10 Finland

Low back pain

1.8

14.1

318

2069

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.8

14.1

298

1900

WX110

NOMESCO Finland

Local anesthesy

1.7

14.0

664

5360

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

3.2

14.0

242

U02

ICPC

Urinary frequency/urgency

2.3

14.0

137

645

A02BC02

ATC

pantoprazole; systemic

1.7

13.9

613

4844

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

3.4

13.9

215

ABD99

NOMESCO Finland

Other operation on spinal cord or nerve for pain or impaired function

30.5

13.9

A46

ICD-10 Finland

Erysipelas

2.2

13.9

154

768

N29

ICPC

Neurological sympt/complt other

6.2

13.9

A41.9

ICD-10 Finland

Sepsis, unspecified

4.0

13.8

143

ABC56

NOMESCO Finland

Decompression of lumbar spinal canal and nerve roots

5.4

13.7

N03AF02

ATC

oxcarbazepine; oral

4.5

13.7

110

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.7

13.6

414

2942

ABB40

NOMESCO Finland

Evacuation of spontaneous haematoma of spinal canal

+∞

13.6

S18

ICPC

Laceration/cut

1.7

13.6

399

2808

M54.2

ICD-10 Finland

Cervicalgia

2.9

13.5

300

J01DB01

ATC

cefalexin; oral

1.8

13.5

794

6792

Q05.2

ICD-10 Finland

Lumbar spina bifida with hydrocephalus

141.8

13.5

A01

ICPC

Pain general/multiple sites

2.8

13.5

350

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.9

13.3

242

1462

XA800

NOMESCO Finland

Neuropsychological investigation

3.6

13.2

169

N45.9

ICD-10 Finland

Orchitis, epididymitis and epididymo-orchitis without abscess

6.4

13.1

3400A

ICD-9 Finland

Multiple sclerosis[SCLEROSIS MULTIPLEX (DISSEMINATA)]

28.8

13.0

NAU20

NOMESCO Finland

Removal of internal fixation device from spine or neck

28.8

13.0

S22.1

ICD-10 Finland

Multiple fractures of thoracic spine

22.9

12.9

S12.7

ICD-10 Finland

Multiple fractures of cervical spine

22.9

12.9

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

3.6

12.7

165

D43.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Spinal cord

+∞

12.5

G91.9

ICD-10 Finland

Hydrocephalus, unspecified

+∞

12.5

G91.2

ICD-10 Finland

Normal-pressure hydrocephalus

+∞

12.5

G93.0

ICD-10 Finland

Cerebral cysts

+∞

12.5

ABE40

NOMESCO Finland

Operation for hydromyelia

+∞

12.5

NA2DG

NOMESCO Finland

Thoracal spine very extensive MRI examination with high intensity magnet

24.6

12.5

G04BD11

ATC

fesoterodine; oral

4.3

12.4

112

J01DA01

ATC

[U] cefalexin; systemic

1.6

12.3

596

4753

N06AA10

ATC

nortriptyline; systemic

5.2

12.2

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

3.1

12.1

221

R5140

NOMESCO Finland

Monitoring the use of the aid

2.3

12.1

119

557

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.9

12.1

274

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

4.3

12.0

106

SPAT1310

SPAT

Counselling related to known health issue

1.7

12.0

303

2022

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

2.1

11.9

140

713

T90.5

ICD-10 Finland

Sequelae of intracranial injury

8.5

11.8

X58

ICD-10 Finland

Exposure to other specified factors

2.1

11.8

140

717

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.8

11.8

290

KCE02

NOMESCO Finland

Transluminal endoscopic extraction of calculus from bladder

10.7

11.8

Z50.1

ICD-10 Finland

Other physical therapy

3.1

11.7

209

N21.0

ICD-10 Finland

Calculus in bladder

7.8

11.7

Z73.3

ICD-10 Finland

Stress, not elsewhere classified

7.8

11.7

L04AA31

ATC

teriflunomide; oral

23.2

11.6

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.2

11.6

125

614

Z2446

NOMESCO Finland

Social worker

2.8

11.6

288

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.9

11.5

258

AA7AA

NOMESCO Finland

Liquor cerebri shunt X-ray examinatin without contrast

+∞

11.5

S34.0

ICD-10 Finland

Concussion and oedema of lumbar spinal cord

+∞

11.5

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.7

11.3

263

1706

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.7

11.3

270

1769

AEA24

NOMESCO Finland

Removal of spinal stimulation elecrode

35.4

11.3

AEA00

NOMESCO Finland

Replacement of impulse generator of stimulation device in the nervous system

35.4

11.3

A02BC03

ATC

lansoprazole; oral

1.7

11.2

273

1798

164

Kela drug reimbursment

Fingolimod

20.3

11.1

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.6

11.1

389

2832

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.7

11.0

291

1960

L99

ICPC

Musculoskeletal disease other

5.2

11.0

NAJ12

NOMESCO Finland

Posterior reduction of fracture of cervical spine

43.8

10.9

UJF32

NOMESCO Finland

Coloscopy

1.7

10.9

251

1622

NG4AA

NOMESCO Finland

Lower leg X-ray examination

4.4

10.9

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.8

10.8

251

XA402

NOMESCO Finland

ENMG

4.8

10.8

WX702

NOMESCO Finland

Supraglottic ventilation device

2.9

10.8

245

L04AA27

ATC

fingolimod; oral

28.3

10.7

L04AX07

ATC

dimethyl fumarate; oral

28.3

10.7

M01AH01

ATC

celecoxib; oral (coxibs)

1.9

10.7

176

1018

L29

ICPC

Musculoskeletal sympt/complt other

2.6

10.7

314

N30.1

ICD-10 Finland

Interstitial cystitis (chronic)

7.7

10.7

G04BD

ATC

Drugs for urinary frequency and incontinence

60.6

10.6

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.8

10.6

265

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

2.5

10.6

354

ZZA00

NOMESCO Finland

Split skin graft

4.1

10.6

100

WX002

NOMESCO Finland

Sedation and analgesia

1.8

10.6

188

1117

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.1

10.5

116

575

R50.9

ICD-10 Finland

Fever, unspecified

2.0

10.5

144

779

ZXD35

NOMESCO Finland

Usual procedure

3.5

10.5

142

G82

ICD-10 Finland

Paraplegia and tetraplegia

111.1

10.4

7410D

ICD-9 Finland

Spina bifida, With hydrocephalus[SPINA BIFIDA APERTA CUM HYDROCEPHALO REG LUMBALIS]

111.1

10.4

QDG10

NOMESCO Finland

Excision and repair of bedsore of lower limb

+∞

10.4

T09.3

ICD-10 Finland

Injury of spinal cord, level unspecified

+∞

10.4

3499X

ICD-9 Finland

Other and unspecified disorders of the nervous system, Unspecified disorders of nervous system

+∞

10.4

AAF20

NOMESCO Finland

Revision of shunt of ventricle of brain

+∞

10.4

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

3.4

10.4

148

R53

ICD-10 Finland

Malaise and fatigue

1.8

10.4

182

1076

B01AB05

ATC

enoxaparin; parenteral

1.7

10.4

284

1925

A29

ICPC

General symptom/complaint other

2.2

10.4

113

557

ABC50

NOMESCO Finland

Decopression of cervical spinal canal and nerve roots

32.9

10.3

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

5.4

10.3

A02BC01

ATC

omeprazole; systemic

1.7

10.2

267

1785

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.9

10.2

165

951

R60.0

ICD-10 Finland

Localized oedema

2.2

10.1

108

525

SPAT1149

SPAT

Suture or treatment of traumatic wound

2.0

10.1

131

692

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.8

10.1

238

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.8

10.1

248

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.6

10.0

389

2884

ABC63

NOMESCO Finland

Decompression of thoracic spinal cord

40.5

10.0

N06BA07

ATC

modafinil; oral

16.9

9.9

G04CA01

ATC

alfuzosin; oral

2.1

9.9

118

606

M41.9

ICD-10 Finland

Scoliosis, unspecified

8.2

9.9

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

4.3

9.8

D17

ICPC

Incontinence of bowel

8.8

9.8

G55.2*M47.9

ICD-10 Finland

Nerve root and plexus compressions in spondylosis

6.2

9.7

U70

ICPC

Pyelonephritis/pyelitis

6.2

9.7

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

3.7

9.7

114

L02

ICPC

Back symptom/complaint

2.3

9.7

417

N07XX09

ATC

[U] dimethyl fumarate; oral

55.5

9.7

D12

ICPC

Constipation

3.5

9.6

125

S72.4

ICD-10 Finland

Fracture of lower end of femur

7.9

9.6

G47.3

ICD-10 Finland

Sleep apnoea

1.7

9.6

208

1316

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

4.7

9.6

GBB00

NOMESCO Finland

Tracheostomy

7.2

9.5

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.9

9.5

158

917

ZXE40

NOMESCO Finland

More than seven and less than nine hours

4.4

9.5

U28

ICPC

Limited function/disability (U)

7.6

9.4

AEA30

NOMESCO Finland

Replacement of implanted pump of injection device in the nervous system

100.9

9.4

SPAT1254

SPAT

Administration of medicine

1.9

9.4

139

771

KH1AT

NOMESCO Finland

Urinary tract cathetrisation with ultrasound guidance

30.3

9.4

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

5.4

9.4

G91.1

ICD-10 Finland

Obstructive hydrocephalus

+∞

9.4

V89

ICD-10 Finland

Motor- or nonmotor-vehicle accident, type of vehicle unspecified

21.9

9.4

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.4

9.3

338

Y96.9

ICD-10 Finland

Unspecified type of accident

5.3

9.3

M79.6

ICD-10 Finland

Pain in limb

1.6

9.2

315

2253

XJH00

NOMESCO Finland

Transanal ultrasonography

2.5

9.1

305

SPAT1255

SPAT

Intravenous administration of medicine

2.4

9.0

318

JN3AD

NOMESCO Finland

Abdominal CT examination

2.4

9.0

350

34099

ICD-8 Finland

Multiple sclerosis

37.0

9.0

G83.1

ICD-10 Finland

Monoplegia of lower limb

37.0

9.0

N39.9

ICD-10 Finland

Disorder of urinary system, unspecified

5.1

9.0

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

2.7

9.0

237

SPAT1249

SPAT

Treatment-related counselling outside office

1.5

9.0

372

2779

N07BC02

ATC

methadone; systemic

18.8

8.9

XX1ZW

NOMESCO Finland

Very extensive written report from radiologist

18.8

8.9

Y86

ICD-10 Finland

Sequelae of other accidents

12.7

8.9

A02BA02

ATC

ranitidine; systemic

1.7

8.9

182

1131

WX720

NOMESCO Finland

Own respiration

3.1

8.8

151

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

8.8

422

3251

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.4

8.8

308

N30

ICD-10 Finland

Cystitis

2.3

8.8

350

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

6.0

8.8

R35

ICD-10 Finland

Polyuria

2.4

8.8

298

S13.1

ICD-10 Finland

Dislocation of cervical vertebra

50.4

8.7

R51

NOMESCO Finland

Aids services

50.4

8.7

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

3.3

8.7

131

R11

ICD-10 Finland

Nausea and vomiting

2.3

8.7

366

N05BA04

ATC

oxazepam; oral

1.7

8.7

217

1426

Z73.6

ICD-10 Finland

Limitation of activities due to disability

8.3

8.6

XX6XT

NOMESCO Finland

Other intravascular therapy with radiological guidance

11.7

8.6

S29

ICPC

Skin symptom/complaint other

1.8

8.5

155

926

L03

ICPC

Low back symptom/complaint

1.7

8.5

213

1398

TAW99

NOMESCO Finland

Other minor neurosurgical procedure

12.9

8.4

M53.1

ICD-10 Finland

Cervicobrachial syndrome

2.1

8.4

100

511

G95

ICD-10 Finland

Other diseases of spinal cord

+∞

8.3

34900

ICD-8 Finland

Other diseases of spinal cord, Syringomyelia

+∞

8.3

Q05.9

ICD-10 Finland

Spina bifida, unspecified

+∞

8.3

ABC33

NOMESCO Finland

Decompression of thoracic nerve roots

+∞

8.3

3361A

ICD-9 Finland

Other diseases of spinal cord, Vascular myelopathies

+∞

8.3

3368X

ICD-9 Finland

Other diseases of spinal cord, Other myelopathy

+∞

8.3

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

4.7

8.3

WX882

NOMESCO Finland

High dependency care

3.4

8.3

119

SPAT1285

SPAT

Provision of consultation response

2.6

8.3

242

N30.2

ICD-10 Finland

Other chronic cystitis

7.1

8.3

G54.0

ICD-10 Finland

Brachial plexus disorders

4.3

8.2

ZXE00

NOMESCO Finland

One hour or less

1.5

8.2

364

2748

A41.8

ICD-10 Finland

Other specified sepsis

5.4

8.2

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.7

8.1

212

SPAT1293

SPAT

Other function in accordance with rehabilitation guidance nomenclature

8.2

8.1

SPAT1125

SPAT

Stoma care and guidance

4.9

8.1

R32

ICD-10 Finland

Unspecified urinary incontinence

4.0

8.1

KDV20

NOMESCO Finland

Submucous urethral injection

33.6

8.1

TAB22

NOMESCO Finland

Stoppin epidural fluid escape with coagulated blood

11.8

8.1

S12.0

ICD-10 Finland

Fracture of first cervical vertebra

17.3

8.1

A04

ICPC

Weakness/tiredness general

1.9

8.1

114

623

M41.5

ICD-10 Finland

Other secondary scoliosis

22.2

8.0

A03FA02

ATC

cisapride; oral, rectal

2.2

8.0

354

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.2

8.0

392

SAA01

NOMESCO Finland

Simple examination of mouth

1.5

8.0

639

5445

C08CA05

ATC

nifedipine; systemic

2.4

8.0

281

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.5

7.9

254

R13

ICD-10 Finland

Dysphagia

2.3

7.9

306

359

Kela drug reimbursment

Mirabegroni

13.1

7.9

K07

ICPC

Swollen ankles/oedema

2.8

7.9

170

J01MA01

ATC

ofloxacin; systemic

2.1

7.8

439

R1410

NOMESCO Finland

Drawing up a rehabilitation plan

8.5

7.8

S01

ICPC

Pain/tenderness of skin

2.9

7.8

158

N03AF01

ATC

carbamazepine; oral, rectal

2.5

7.8

239

NAG63

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, more than 3 vertebraea

9.5

7.8

SPAT1234

SPAT

Support of social functional capacity

2.8

7.8

181

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

3.4

7.8

104

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.2

7.8

357

N02AC04

ATC

dextropropoxyphene; oral

3.0

7.7

152

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.8

7.7

183

K90

ICPC

Stroke/cerebrovascular accident

4.0

7.7

H04.10

ICD-10 Finland

Dry eye syndrome

2.1

7.7

451

E0000UV

ATC

1.5

7.6

345

2605

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.9

7.6

162

G99.2*M51.0

ICD-10 Finland

Lumbar and other intervertebral disc disorders with myelopathy

25.2

7.6

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.4

7.6

101

M96.1

ICD-10 Finland

Postlaminectomy syndrome, not elsewhere classified

10.1

7.5

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.5

7.5

301

2216

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

2.5

7.5

243

UJH02

NOMESCO Finland

Anoscopy

2.9

7.5

158

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

3.3

7.5

113

S82.3

ICD-10 Finland

Fracture of lower end of tibia

4.3

7.4

R42

ICD-10 Finland

Dizziness and giddiness

1.7

7.4

176

1135

G37.3

ICD-10 Finland

Acute transverse myelitis in demyelinating disease of central nervous system

80.6

7.4

NA7DM

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with 3 Tesla magnet

80.6

7.4

G06.1

ICD-10 Finland

Intraspinal abscess and granuloma

80.6

7.4

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

3.4

7.4

103

N06AX11

ATC

mirtazapine; oral

1.5

7.4

277

2007

M01AE03

ATC

ketoprofen; systemic, rectal

1.5

7.4

336

2542

H53.2

ICD-10 Finland

Diplopia

3.5

7.3

NH1BA

NOMESCO Finland

Ankle extensive X-ray examination

3.6

7.3

M05BA04

ATC

alendronic acid; oral

2.2

7.3

334

80691

ICD-8 Finland

Fracture and fracture dislocation of vertebral column with spinal cord lesion, Thoracica, Sequelae

+∞

7.3

G91.0

ICD-10 Finland

Communicating hydrocephalus

+∞

7.3

C72.09

ICD-10 Finland

Malignant tumor of the spinal cord other histology

+∞

7.3

AAF99

NOMESCO Finland

Other shunt operation on ventricle of brain or intracerebral cyst

+∞

7.3

G99.2*M47.0

ICD-10 Finland

Anterior spinal and vertebral artery compression syndromes

+∞

7.3

G96.0

ICD-10 Finland

Cerebrospinal fluid leak

+∞

7.3

C72.1

ICD-10 Finland

Malignant neoplasm: Cauda equina

+∞

7.3

M41.4

ICD-10 Finland

Neuromuscular scoliosis

+∞

7.3

T85.7

ICD-10 Finland

Infection and inflammatory reaction due to other internal prosthetic devices, implants and grafts

+∞

7.3

G93.1

ICD-10 Finland

Anoxic brain damage, not elsewhere classified

+∞

7.3

Y85.0

ICD-10 Finland

Sequelae of motor-vehicle accident

+∞

7.3

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.3

7.3

280

A08

ICPC

Swelling

2.8

7.3

161

SAA03

NOMESCO Finland

Extended examination of mouth

1.5

7.3

341

2587

M54.6

ICD-10 Finland

Pain in thoracic spine

2.3

7.3

281

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.2

7.2

327

Z93.5

ICD-10 Finland

Cystostomy status

15.9

7.2

F43.1

ICD-10 Finland

Post-traumatic stress disorder

4.1

7.2

H53.1

ICD-10 Finland

Subjective visual disturbances

2.4

7.2

243

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.1

7.2

405

G81.1

ICD-10 Finland

Spastic hemiplegia

30.2

7.2

SPAT1153

SPAT

Removal of sutures

1.5

7.1

283

2074

N03AX11

ATC

topiramate; oral

3.6

7.1

N06AB04

ATC

citalopram; systemic

1.6

7.1

189

1256

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.4

7.1

238

L03.0

ICD-10 Finland

Cellulitis of finger and toe

2.2

7.1

346

N04BC05

ATC

pramipexole; oral

2.2

7.1

333

G04.9

ICD-10 Finland

Encephalitis, myelitis and encephalomyelitis, unspecified

12.1

7.1

PA7BD

NOMESCO Finland

CT angiography of neck and brain

5.7

7.1

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

3.1

7.1

118

S06.0

ICD-10 Finland

Concussion

2.0

7.0

499

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

2.3

7.0

260

F43.29

ICD-10 Finland

Adaptation disorder UNS

4.0

7.0

SPAT1211

SPAT

Application of soft bandage

2.0

7.0

445

R60.9

ICD-10 Finland

Oedema, unspecified

2.5

7.0

203

N06AB10

ATC

escitalopram; oral

1.6

7.0

170

1104

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

6.4

7.0

V29.9

ICD-10 Finland

Motorcycle rider [any] injured in unspecified traffic accident

6.4

7.0

XF400

NOMESCO Finland

ECG with 12 standard connections

1.7

6.9

141

872

XX3DW

NOMESCO Finland

Time consuming IT work

1.9

6.9

509

ZXM20

NOMESCO Finland

Intraoperative use of computerised tomography

7.6

6.9

353

Kela drug reimbursment

Cladribine and fingolimod

13.9

6.9

F43.20

ICD-10 Finland

Adaptation disorder with short-term depression

4.9

6.9

XG466

NOMESCO Finland

Sleep oxymetry

3.0

6.8

121

M79.0

ICD-10 Finland

Rheumatism, unspecified

3.0

6.8

121

Z71.8

ICD-10 Finland

Other specified counselling

1.6

6.8

206

1413

N30.8

ICD-10 Finland

Other cystitis

6.8

NFQ20

NOMESCO Finland

Amputation of femur

6.8

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

4.0

6.8

G04BE01

ATC

alprostadil; parenteral, urethral

3.9

6.8

S14

ICPC

Burn/scald

2.9

6.8

137

NAG41

NOMESCO Finland

Anterior fusion of cervical spine with fixation

9.4

6.8

R06.0

ICD-10 Finland

Dyspnoea

1.6

6.8

215

1492

K02.1

ICD-10 Finland

Caries of dentine

1.4

6.8

503

4161

D33.40

ICD-10 Finland

Benign glioma of the spinal cord (grade I)

40.3

6.8

L16

ICPC

Ankle symptom/complaint

2.0

6.8

462

N32.9

ICD-10 Finland

Bladder disorder, unspecified

16.8

6.7

U72

ICPC

Urethritis

3.6

6.7

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

3.6

6.7

NA1BA

NOMESCO Finland

Cervical spine extensive X-ray examination without contrast

7.2

6.7

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

4.0

6.7

N17

ICPC

Vertigo/dizziness

1.9

6.7

499

J01CF05

ATC

flucloxacillin; systemic

2.8

6.7

146

NAG42

NOMESCO Finland

Posterior fusion of cervical spine with or without fixation

22.7

6.7

ABW99

NOMESCO Finland

Other operation on spinal cord or nerve root

22.7

6.7

TAA40

NOMESCO Finland

Cathetrisation of cerebrospinal fluid through skin

22.7

6.7

AEA20

NOMESCO Finland

Removal of impulse generator of stimulation device in the nervous system

22.7

6.7

R2120

NOMESCO Finland

Counselling and guidance concerning rehabilitation services and social security

5.9

6.6

M54.3

ICD-10 Finland

Sciatica

2.3

6.6

261

NA2AD

NOMESCO Finland

Thoracic spine CT examination

8.8

6.6

J01CA04

ATC

amoxicillin; systemic

1.5

6.5

747

6676

WX892

NOMESCO Finland

Monitored bed care

2.1

6.5

344

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

3.1

6.5

114

NAG62

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, 2-3 vertebraea

3.6

6.5

B01AA03

ATC

warfarin; systemic

1.6

6.5

160

1043

R1210

NOMESCO Finland

Medical assessment of need and possibilities to rehabilitation

5.1

6.5

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

5.1

6.5

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.3

6.5

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.9

6.5

129

SPAT1296

SPAT

Other function in accordance with occupational therapy nomenclature

6.2

6.5

M81.9

ICD-10 Finland

Osteoporosis, unspecified

2.8

6.5

137

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.1

6.5

323

S34.1

ICD-10 Finland

Other injury of lumbar spinal cord

70.3

6.4

NA7CM

NOMESCO Finland

Spine and spinal cord extensive MRI examination with 3 Tesla magnet

70.3

6.4

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.2

6.4

278

J96.1

ICD-10 Finland

Chronic respiratory failure

3.6

6.4

U99

ICPC

Urinary disease other

7.5

6.4

TAC99

NOMESCO Finland

Other blockade for chronic pain

7.5

6.4

AB5BT

NOMESCO Finland

Blockage of nerv root with X-ray guidance

7.5

6.4

ZZH21

NOMESCO Finland

Graft of patients own bone, small pieces

3.7

6.4

B01AC07

ATC

dipyridamole; systemic

2.9

6.4

132

N04BD01

ATC

selegiline; oral

4.4

6.4

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.5

6.4

246

1785

G55.1*M51.1

ICD-10 Finland

Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions

3.4

6.4

M86.9

ICD-10 Finland

Osteomyelitis, unspecified

6.6

6.3

R90.8

ICD-10 Finland

Other abnormal findings on diagnostic imaging of central nervous system

6.6

6.3

PA7CD

NOMESCO Finland

CT angiography of neck and brain, extensive

8.2

6.3

7819X

ICD-9 Finland

Symptoms involving nervous and musculoskeletal systems, Other symptoms involving nervous and musculoskeletal systems[SYMPTOMATA ALIA SYSTEMATIS NERVORUM ET MUSCULOSCEL]

5.2

6.3

WX199

NOMESCO Finland

Other local analgesia

3.5

6.3

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

4.2

6.3

M05BX04

ATC

denosumab; parenteral

2.5

6.3

189

NF3AA

NOMESCO Finland

Femur X-ray examination

4.0

6.3

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

3.2

6.3

100

J01XX08

ATC

linezolid; systemic

9.3

6.3

S28

ICPC

Limited function/disability (S)

9.3

6.3

KH1EE

NOMESCO Finland

Urologic ultrasound examination

9.3

6.3

G36.9

ICD-10 Finland

Acute disseminated demyelination, unspecified

18.1

6.3

L14

ICPC

Leg/thigh symptom/complaint

2.1

6.3

323

80690

ICD-8 Finland

Fracture and fracture dislocation of vertebral column with spinal cord lesion, Cervicalis, Sequelae

+∞

6.3

5965X

ICD-9 Finland

Other disorders of bladder, Other functional disorders of bladder[ALIA FUNCTIO LAESA VESICAE URINARIAE]

+∞

6.3

AAF25

NOMESCO Finland

Removal of shunt of ventricle of brain

+∞

6.3

A123_

NOMESCO Finland

+∞

6.3

1601

FHL

Cystometry

+∞

6.3

2133

FHL

Suntin revisio

+∞

6.3

M49.4

ICD-10 Finland

Neuropathic spondylopathy

+∞

6.3

T85.0

ICD-10 Finland

Mechanical complication of ventricular intracranial (communicating) shunt

+∞

6.3

G992, M480

ICD-10 Finland

+∞

6.3

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.6

6.2

173

1163

SAA04

NOMESCO Finland

Special inverstigation of mouth

2.3

6.2

235

XF600

NOMESCO Finland

Bloodpressure measurement

2.3

6.2

256

WZA90

NOMESCO Finland

Other doctors statement

1.6

6.2

195

1349

R30.0

ICD-10 Finland

Dysuria

2.9

6.2

129

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.7

6.2

116

698

WX872

NOMESCO Finland

Intensive care

2.3

6.2

224

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.2

6.2

257

ZXE17

NOMESCO Finland

Procedure duration 150 to 179 minutes

5.8

6.2

KF8AE

NOMESCO Finland

Ultrasound examination of scrotum

3.3

6.1

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

4.3

6.1

G44.2

ICD-10 Finland

Tension-type headache

1.8

6.1

109

646

R52.1

ICD-10 Finland

Chronic intractable pain

7.7

6.1

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

4.1

6.1

1530

FHL

Urethrocystoscopy

3.8

6.1

A02BC05

ATC

esomeprazole; systemic

1.4

6.1

351

2754

V28.2

ICD-10 Finland

Motorcycle rider injured in noncollision transport accident, unspecified motorcycle rider injured in nontraffic accident

12.6

6.1

NA3CM

NOMESCO Finland

Lumbar spine extensive MRI examination with 3 Tesla magnet

12.6

6.1

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.0

6.0

392

A02BA04

ATC

nizatidine; systemic

2.0

6.0

365

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.7

6.0

149

SAA02

NOMESCO Finland

Basic examination of mouth

1.4

6.0

572

4899

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3026008) Bacteria identified in Urine by Culture

602

2500

4.04

116.95

7.6

2.9

—

(3000850) Epithelial cells [#/volume] in Urine

406

1824

2.92

60.45

5.1

2.6

e6/l

4.3

5.6

1.42

382

1605

(3044290) Cell count panel - Cerebral spinal fluid

143

6.84

56.15

2.5

1.2

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

102

181

6.10

55.86

1.9

1.2

mg/l

968.5

514.7

0.94

168

(3023368) Bacteria identified in Blood by Culture

470

2374

2.69

54.72

7.1

4.3

—

(3031040) Bacteria [#/volume] in Urine by Automated count

851

5766

2.97

54.35

12.1

4.2

e6/l

4656.9

2485.6

0.47

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

157

6.22

51.21

2.5

1.2

e6/l

42.5

39.9

0.02

123

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

157

6.22

51.21

2.5

1.2

e6/l

1054.4

1436.7

0.15

128

(3026782) Osmolality of Urine

368

1743

2.65

47.56

4.7

2.8

mosm/kgh2o

503.2

561.5

6.74

346

1483

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

463

2468

2.49

46.44

2.5

2.1

u/l

196.0

260.9

0.76

432

2314

(3016018) Differential panel - Cerebral spinal fluid

8.81

45.40

2.7

1.1

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

543

3159

2.39

44.25

6.0

3.2

—

(3037467) Urinalysis macro (dipstick) panel - Urine

853

6078

2.68

44.02

9.4

4.1

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

165

5.56

43.23

1.7

1.1

mmol/l

3.6

3.8

0.35

154

(3032080) INR in Blood by Coagulation assay

577

3492

2.34

42.35

9.8

9.2

inr

1.2

0.40

207

1021

(3007853) Bacteria identified in Skin by Aerobe culture

250

1034

2.82

41.50

3.2

1.7

—

(3002582) Erythrocytes [#/volume] in Urine

471

2636

2.36

41.20

6.6

3.2

e6/l

23.0

91.2

1.98

424

2040

(3035350) Ketones [Presence] in Urine by Test strip

663

4291

2.33

41.10

7.5

3.4

estimate

0.0

0.00

196

819

(3021601) Nitrite [Presence] in Urine by Test strip

662

4307

2.31

40.18

9.3

4.7

estimate

0.0

0.50

192

828

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

662

4311

2.31

40.03

8.4

7.0

mmol/l

1.2

2.17

527

3653

(3009261) Glucose [Presence] in Urine by Test strip

665

4347

2.30

39.73

7.6

3.5

estimate

0.0

0.80

195

787

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

8.49

37.43

3.0

1.3

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

743

5169

2.29

37.08

7.1

4.9

mmol/l

6.5

6.7

1.24

713

4840

(3041096) Erythrocytes [Presence] in Urine by Automated

429

2414

2.26

35.92

8.0

3.2

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

8.04

35.09

1.2

1.1

mg/l

43.0

33.2

0.44

(3024561) Albumin [Mass/volume] in Serum or Plasma

582

3730

2.16

34.83

6.3

4.8

g/l

33.9

35.7

9.90

551

3470

(36304419) Bacteria [Presence] in Urine

417

2354

2.23

34.32

5.4

3.0

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

8.00

34.22

1.1

1.0

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

537

3358

2.15

33.99

8.4

3.6

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

598

3898

2.14

33.95

8.0

6.3

mmol/l

1.2

2.91

544

3535

(3018095) Leukocytes [#/volume] in Urine

502

3083

2.14

33.03

7.6

3.7

e6/l

300.8

115.9

0.75

437

2196

(3030467) Casts [#/volume] in Urine by Automated count

414

2408

2.14

30.91

5.4

3.1

e6/l

0.3

0.5

1.90

366

1826

(40761536) Microorganisms panel - Urine sediment

183

757

2.69

29.66

9.9

3.8

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

7.23

28.13

1.2

1.1

mg/l

264.1

250.6

0.18

(3003396) Base excess in Arterial blood by calculation

211

966

2.46

27.58

8.7

8.9

mmol/l

2.2

1.3

2.80

171

751

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

203

923

2.46

26.89

5.8

3.4

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

6.38

26.78

1.1

1.0

—

(3029937) Albumin [Presence] in Urine by Test strip

386

2295

2.04

26.30

9.5

3.7

estimate

0.0

0.14

196

797

(3042936) Bacteria identified in Isolate by Culture

255

1303

2.24

25.71

3.3

2.0

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

207

968

2.40

25.69

8.7

8.8

kpa

5.3

5.1

1.51

202

929

(3027801) Oxygen [Partial pressure] in Arterial blood

207

968

2.40

25.69

8.7

8.8

kpa

12.5

11.9

0.91

201

931

(3012095) Magnesium [Moles/volume] in Serum or Plasma

269

1410

2.19

25.44

4.2

3.6

mmol/l

0.8

0.06

248

1330

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

115

4.88

24.04

10.5

6.6

mg/l

12.1

11.1

0.73

105

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

8.78

23.73

2.0

1.1

69.0

70.6

—

(3023410) Appearance of Cerebral spinal fluid

6.02

23.66

3.0

1.3

—

(3016502) Oxygen saturation in Arterial blood

187

868

2.39

23.46

9.2

9.4

96.2

95.4

1.13

182

843

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

260

1385

2.14

23.39

2.4

1.9

—

(3019060) Gas panel - Arterial blood

139

562

2.68

23.33

6.8

5.6

—

(42870588) Differential panel, method unspecified - Blood

457

2974

1.91

23.28

8.6

5.8

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

241

1249

2.18

23.24

3.6

2.1

29.7

29.9

0.28

232

1202

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

10.21

23.00

3.0

1.4

—

(3018418) pH of Serum or Plasma

403

2527

1.93

22.90

5.1

4.0

7.4

1.25

105

481

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

144

598

2.62

22.89

1.9

1.6

—

(4027681)

7.12

22.57

1.3

1.1

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

131

527

2.68

22.17

10.0

7.9

mmol/l

26.0

24.5

5.14

125

495

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

6.77

20.93

1.1

1.0

u/l

1.1

1.0

1.04

(3047181) Lactate [Moles/volume] in Blood

268

3.26

20.80

8.6

8.1

mmol/l

1.3

0.14

236

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

258

3.31

20.75

2.5

1.6

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

6.56

19.72

3.5

2.4

—

(3006315) Basophils [#/volume] in Blood

603

4433

1.78

19.52

9.2

5.8

e9/l

0.0

0.77

539

3855

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

577

4188

1.78

19.52

5.7

4.0

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

6.43

19.35

3.6

2.3

14.1

13.8

0.05

(3012501) Base excess in Blood by calculation

188

3.61

19.33

6.9

4.7

mmol/l

3.8

2.6

1.45

127

(3005719) IgG [Mass/volume] in Serum or Plasma

149

679

2.38

19.30

4.0

2.9

g/l

9.3

10.9

4.31

130

625

(3019150) Specific gravity of Urine by Refractometry

311

1877

1.91

19.24

7.3

3.7

kg/l

1.0

0.18

256

(3022096) Basophils/100 leukocytes in Blood

562

4063

1.77

19.14

9.6

6.0

0.6

0.7

0.55

529

3794

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

304

1824

1.91

19.13

1.7

pmol/l

407.7

32143279.5

1.91

260

1512

(3001604) Monocytes [#/volume] in Blood

599

4414

1.77

19.05

9.2

5.8

e9/l

0.6

0.00

536

3835

(3019198) Lymphocytes [#/volume] in Blood

611

4533

1.76

18.94

9.2

5.9

e9/l

1.8

2.0

1.50

548

4023

(3019069) Monocytes/100 leukocytes in Blood

577

4213

1.76

18.89

9.7

6.2

8.6

0.26

547

3950

(3006504) Eosinophils/100 leukocytes in Blood

573

4187

1.75

18.61

9.5

6.0

2.8

2.9

0.09

539

3900

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

845

6921

1.89

18.56

9.3

7.5

u/l

81.2

78.7

0.91

808

6492

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

617

4617

1.75

18.30

7.3

6.4

umol/l

9.8

11.5

5.20

589

4380

(3011412) CD3 cells [#/volume] in Blood

5.28

18.25

4.2

2.2

e9/l

1.0

1.1

0.21

(3010421) pH of Blood

226

3.29

18.21

7.0

4.4

7.4

0.75

185

(3013115) Eosinophils [#/volume] in Blood

612

4591

1.73

17.79

9.5

6.1

e9/l

0.2

0.04

547

4057

(3003458) Phosphate [Moles/volume] in Serum or Plasma

211

1147

2.03

17.52

5.5

6.0

mmol/l

1.0

0.60

194

1065

(3002030) Lymphocytes/100 leukocytes in Blood

582

4319

1.72

17.48

9.8

6.0

26.9

28.0

1.41

552

4026

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

507

3625

1.73

17.41

2.5

2.2

nmol/l

80.7

76.7

2.14

455

3262

(3018010) Neutrophils/100 leukocytes in Blood

574

4256

1.71

17.19

9.3

5.8

57.9

57.2

0.69

543

3993

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

186

973

2.09

17.11

2.3

1.8

—

(3019309) Folate [Moles/volume] in Red Blood Cells

263

1555

1.90

17.06

2.0

1.7

nmol/l

1255.6

1197.0

0.46

220

1166

(3027945) Reticulocytes/100 erythrocytes in Blood

180

943

2.08

16.45

3.8

2.9

1.8

0.01

156

853

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

462

3262

1.71

16.30

4.3

3.4

ng/l

39.7

51.7

0.48

351

2227

(3020779) Urea [Moles/volume] in Serum or Plasma

154

763

2.18

16.25

6.2

8.2

mmol/l

7.8

9.7

3.66

149

719

(3021960) Folate [Moles/volume] in Serum or Plasma

316

2008

1.80

16.16

1.7

1.5

nmol/l

20.3

20.6

0.11

273

1714

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

13.81

15.94

1.8

2.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

26.71

15.62

1.0

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

659

5151

1.68

15.53

11.9

9.2

e9/l

4.2

4.1

1.12

592

4504

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

403

2772

1.71

15.46

2.9

2.5

u/l

55.5

57.9

0.23

369

2557

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

106

457

2.46

15.44

11.4

12.9

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

142

700

2.18

15.14

5.4

3.9

mmol/l

1.2

1.27

119

608

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

180

971

2.02

15.12

2.4

1.8

—

(40767503) Oxygen content in Capillary blood by calculation

189

3.24

14.99

3.3

2.7

16.4

16.3

0.06

103

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

333

2192

1.74

14.87

2.4

2.1

mg/l

3.1

3.0

0.30

298

1862

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

6.99

14.45

1.2

1.1

ng/l

106.7

233.9

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

242

2.93

14.44

5.0

3.1

mmol/l

25.4

25.1

0.20

216

(1616796) Gas panel - Central venous blood

194

3.15

14.36

6.4

3.9

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

157

822

2.06

14.28

2.2

2.3

g/l

0.2

1.60

148

767

(3023520) Reticulocytes [#/volume] in Blood

139

695

2.14

14.27

2.6

3.0

e9/l

68.6

70.3

0.22

110

542

(3003181) Sodium [Moles/volume] in Urine

136

3.56

13.99

1.7

1.5

mmol/l

56.1

62.7

0.54

116

(3044640) Blood type and Crossmatch panel - Blood

397

2801

1.65

13.39

3.6

2.4

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

409

2912

1.64

13.28

4.1

3.3

u/l

28.8

32.8

3.66

386

2759

(3013707) Erythrocyte sedimentation rate by Westergren method

788

6581

1.66

13.22

4.8

4.0

mm/h

15.5

11.7

6.75

730

6061

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

255

1612

1.75

12.89

4.4

3.6

ng/l

138.7

468.1

2.24

184

1237

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

10.89

12.87

1.1

1.2

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

348

2.50

12.83

2.9

2.0

ug/l

2.1

2.3

0.03

312

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

11.94

12.65

1.0

—

(3040151) Glucose [Moles/volume] in Capillary blood

3.83

12.35

188.1

7.4

mmol/l

6.6

7.1

0.47

(3021901) Oxygen saturation in Capillary blood

174

3.09

12.31

4.2

2.8

—

(3009343) pH of Capillary blood

120

607

2.09

11.91

5.4

4.0

7.4

0.10

(3013247) Albumin in CSF/Albumin in Serum or Plasma

12.12

11.75

1.0

mg/g

5.6

6.3

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

120

616

2.06

11.45

5.4

3.9

kpa

5.3

5.2

0.83

110

577

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

115

582

2.09

11.40

5.2

4.0

mmol/l

3.2

1.8

2.98

435

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

5.45

11.38

1.1

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

466

3525

1.55

11.20

2.1

1.9

pmol/l

93.5

95.0

0.24

257

1839

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

345

2442

1.60

11.06

3.0

ng/l

1130.9

1315.5

0.53

291

2057

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

104

513

2.13

11.02

1.6

1.5

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

4.71

10.98

1.4

2.3

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

4.98

10.76

1.1

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

289

1976

1.62

10.62

2.5

1.7

mg/l

1.1

0.07

232

1510

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

168

2.88

9.95

1.7

1.5

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

5.94

9.61

1.1

—

(3037522) Nuclear Ab [Titer] in Serum

189

1196

1.70

9.27

1.4

1.3

titre

610.6

441.7

0.67

252

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

100

3.37

9.22

1.2

1.1

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

712

6040

1.49

9.10

3.9

3.1

u/l

54.8

50.4

0.52

658

5638

(21494814) CD8 cells/100 lymphocytes in Specimen

6.32

9.01

3.3

1.6

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

6.74

8.91

2.0

1.0

—

(3004588) Protein electrophoresis panel - Serum or Plasma

106

571

1.95

8.82

3.6

2.7

—

(3002179) Metamyelocytes/100 leukocytes in Blood

121

682

1.87

8.79

5.1

4.2

0.5

0.6

0.22

174

(3025159) Blasts/100 leukocytes in Blood

120

678

1.86

8.65

5.3

4.4

0.0

0.6

0.72

184

(3017181) Myelocytes/100 leukocytes in Blood

130

754

1.82

8.62

5.4

4.3

0.9

0.09

235

(3028026) IgM [Mass/volume] in Serum or Plasma

102

548

1.95

8.56

3.8

1.7

g/l

1.0

1.5

2.61

505

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

3.48

8.53

2.8

2.7

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

1009

9317

1.82

8.46

29.1

15.5

mmol/l

139.4

139.7

2.95

996

9061

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

155

953

1.73

8.41

6.0

4.5

u/l

227.2

252.5

1.43

149

905

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

264

2.34

8.40

5.0

3.0

u/ml

0.4

0.3

0.60

147

(3022948) Iron [Moles/volume] in Serum or Plasma

204

1349

1.63

8.40

2.7

2.5

umol/l

10.5

13.4

8.24

191

1250

(3023103) Potassium [Moles/volume] in Serum or Plasma

1010

9341

1.81

8.26

29.2

15.6

mmol/l

4.0

0.70

995

9075

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

987

9071

1.73

8.22

28.4

13.5

mg/l

26.4

24.3

1.13

862

7114

(3001122) Ferritin [Mass/volume] in Serum or Plasma

482

3846

1.44

8.12

3.2

2.8

ug/l

140.3

137.5

0.07

441

3550

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

209

1402

1.60

8.09

5.1

2.9

e6/l

3.1

2.2

0.55

132

783

(3021440) Promyelocytes/100 leukocytes in Blood

123

716

1.81

8.05

5.3

4.4

0.1

0.82

215

(3006184) Hemoglobin [Mass/volume] in Capillary blood

195

2.53

7.99

2.9

2.4

g/l

130.4

130.9

0.05

149

(3020630) Protein [Mass/volume] in Serum or Plasma

119

688

1.82

7.96

3.5

2.9

g/l

65.7

66.8

0.83

112

632

(3014148) Varicella zoster virus Ab [Titer] in Serum

3.22

7.85

1.2

1.1

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

359

2.11

7.82

1.6

1.5

u/ml

8.2

11.3

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

167

1072

1.66

7.70

8.7

7.5

mmol/l

104.1

104.2

0.05

157

1048

(3004451) EKG impression Narrative

4.38

7.70

1.2

1.3

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

119

696

1.79

7.67

3.3

2.8

ng/l

158.1

204.6

0.80

109

633

(3004789) Transferrin [Mass/volume] in Serum or Plasma

188

1245

1.61

7.65

2.6

2.5

g/l

2.3

0.37

176

1155

(3020191) Ethanol [Moles/volume] in Serum or Plasma

3.58

7.44

1.4

1.6

promille

1.3

1.2

0.09

(3026389) Candida sp identified in Specimen by Organism specific culture

3.11

7.20

1.3

1.2

—

(3000494) Fungus identified in Specimen by Culture

166

1083

1.63

7.16

2.0

1.4

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

175

1159

1.60

7.10

2.7

2.6

19.1

23.6

3.69

142

995

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

182

2.48

7.08

3.6

3.7

58.9

57.5

0.26

182

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

902

8193

1.51

6.96

4.8

4.5

mu/l

1.8

2.0

0.82

828

7478

(3022621) pH of Urine by Test strip

531

1.84

6.79

3.8

2.7

—

(3021589) Normoblasts [#/volume] in Blood

487

3989

1.39

6.66

16.6

9.4

e9/l

0.0

0.61

425

3271

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

858

0.42

6.66

1.6

1.7

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

210

1471

1.53

6.64

4.6

2.7

e6/l

1.4

1.0

1.04

136

853

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

375

1.98

6.64

2.1

u/l

37.7

39.1

0.29

338

(3015377) Calcium [Moles/volume] in Serum or Plasma

377

2970

1.41

6.44

3.0

3.4

mmol/l

2.3

2.4

2.32

336

2609

(3030905) Polymorphonuclear cells [#/volume] in Blood

174

2.41

6.28

3.1

3.4

e9/l

4.3

4.4

0.13

174

(3000012) Reticulocyte production index

4.00

6.18

1.4

2.0

—

(3002385) Erythrocyte distribution width [Ratio]

843

7629

1.42

5.98

30.8

16.5

13.9

13.6

6.14

835

7456

(3044889) 12 lead EKG panel

715

6303

1.37

5.88

4.2

3.7

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

279

2.06

5.86

4.2

2.2

97.4

90.5

1.37

262

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

5.54

5.81

2.8

1.6

—

(3033658) Prothrombin time (PT) actual/Normal

289

2211

1.41

5.73

6.4

3.8

90.1

90.6

0.14

281

2154

(3035947) Staphylolysin Ab [Units/volume] in Serum

4.10

5.64

1.3

1.1

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

287

2.00

5.44

1.7

1.6

iu/ml

0.9

0.1

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

117

752

1.62

5.35

8.1

8.0

mmol/l

1.4

1.3

0.56

110

720

(3049717) Cytology report of Urine Cyto stain

353

1.89

5.35

2.5

2.7

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

303

1.96

5.35

2.4

2.9

—

(3022313) Gas panel - Capillary blood

449

1.79

5.34

5.9

4.0

—

(4024509)

3.01

5.28

1.5

1.4

—

(40768797) Stomach Pathology biopsy report

175

1237

1.49

5.25

1.2

—

(3043409) Potassium [Moles/volume] in Arterial blood

243

2.06

5.21

6.0

4.0

mmol/l

3.8

3.9

0.29

225

(3036005) Urine sediment comments by Light microscopy Narrative

+∞

5.21

1.4

0.0

—

(3017732) Neutrophils [#/volume] in Blood

591

1.68

5.19

3.4

2.9

e9/l

3.7

4.1

0.84

471

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

149

1023

1.53

5.13

3.4

2.7

umol/l

4.7

8.0

4.78

122

897

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

276

2133

1.39

5.09

3.3

2.3

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

104

2.64

5.08

2.1

1.9

—

(40760888) Immunoglobulin light chains.free panel - Serum

206

2.13

5.01

6.0

4.2

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

529

1.70

4.94

2.1

1.6

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

235

2.04

4.91

1.4

1.3

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

4.10

4.90

2.8

1.9

ug/l

94.6

55.6

0.56

(3036489) Thrombin time

320

1.89

4.89

4.2

2.0

23.3

21.5

0.43

284

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

588

0.41

4.88

1.2

1.4

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

148

1026

1.51

4.87

1.6

—

(3037756) Immunofixation for Serum or Plasma

183

2.17

4.80

2.0

1.7

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

4.17

4.63

3.0

3.3

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

4.17

4.63

3.0

3.3

—

(3007164) IgA [Mass/volume] in Serum or Plasma

229

1741

1.40

4.62

2.3

1.5

g/l

2.7

2.4

0.28

148

1079

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

3.37

4.61

1.1

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

14.07

4.58

1.0

—

(40760892) CBC W Ordered Manual Differential panel - Blood

261

2037

1.37

4.48

7.3

4.6

—

(40761511) CBC panel - Blood by Automated count

1002

9506

1.51

4.33

25.5

12.8

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

254

1.93

4.31

2.7

2.3

u/l

1324.1

2593.3

0.60

108

(3020891) Body temperature

313

1.83

4.27

6.8

4.5

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

250

1953

1.36

4.24

5.7

3.4

—

(3002032) Base excess in Venous blood by calculation

117

797

1.52

4.19

3.6

3.7

mmol/l

2.7

1.9

1.39

623

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

749

6801

1.30

4.18

3.9

3.8

pmol/l

15.0

14.8

1.59

693

6185

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

4.10

4.16

5.3

2.0

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

100

659

1.57

4.15

1.4

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

128

2.30

4.15

1.3

1.8

g/l

0.6

0.9

1.05

103

(3023419) Bacteria identified in Sputum by Culture

128

2.30

4.15

3.7

2.9

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

195

2.04

4.12

5.4

3.4

mg/l

44.0

23.9

1.57

124

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

4.38

4.09

1.3

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

4.38

4.09

1.3

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

4.38

4.09

1.1

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

2.78

4.03

4.4

2.2

e6/l

700.1

659.0

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

232

1.93

4.01

1.3

1.1

—

(3024869) Neuronal Ab [Presence] in Serum

6.47

3.98

1.0

1.1

—

(3035637) Corticotropin [Mass/volume] in Plasma

100

2.43

3.91

1.1

1.4

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

2.91

3.91

1.4

1.2

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.20

3.89

1.1

1.2

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

4.20

3.89

1.2

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

152

2.14

3.87

2.0

1.6

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

221

1.94

3.86

2.3

1.8

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

2.70

3.83

1.3

g/l

5.1

6.9

1.02

(3028192) IgG subclass 2 [Mass/volume] in Serum

2.70

3.83

1.3

g/l

2.6

0.02

(3024139) IgG subclass 3 [Mass/volume] in Serum

2.70

3.83

1.3

g/l

0.3

0.4

0.44

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

2.70

3.83

3.4

3.0

50.2

41.2

1.02

(3013512) EKG study

315

2581

1.31

3.81

4.4

3.7

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

3.36

3.77

2.5

2.7

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

188

2.00

3.76

1.1

1.2

u/ml

42.7

13.5

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

252

1.86

3.76

1.2

—

22.6

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

115

2.29

3.73

2.1

1.6

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

217

1.92

3.72

2.5

1.8

—

(3022217) INR in Platelet poor plasma by Coagulation assay

147

1075

1.42

3.69

24.1

23.4

inr

1.4

1.3

0.37

145

(3042111) Morphology [Interpretation] in Bone marrow Narrative

149

2.11

3.65

1.9

1.7

—

(4062490)

2.63

3.65

1.6

1.3

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

2.63

3.65

2.3

1.8

—

(3044242) Glucose [Moles/volume] in Arterial blood

2.97

3.58

3.1

3.5

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

185

1.98

3.56

1.5

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

185

1.98

3.56

1.5

1.3

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

265

1.81

3.53

6.2

4.1

mg/l

32.2

44.7

0.46

211

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

237

1.85

3.47

1.2

u/ml

1.6

5.4

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

260

1.80

3.43

5.4

4.1

ratio

1.9

—

(3045414) Leukocytes [Presence] in Urine

382

1.66

3.42

1.8

1.7

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

160

2.03

3.42

2.7

1.8

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

375

1.66

3.40

1.4

2.1

g/l

1.8

1.5

0.91

329

(3004809) Band form neutrophils/100 leukocytes in Blood

147

2.07

3.38

4.3

3.8

1.0

1.4

0.52

127

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

233

1.83

3.33

1.2

u/ml

1.9

2.1

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

2.74

3.33

2.9

1.4

u/l

10.4

14.4

1.68

(21494755) Public health laboratory ask at order entry panel

904

0.61

3.32

1.3

1.4

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

102

2.28

3.30

5.0

4.4

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

264

1.77

3.28

6.3

4.1

mg/l

48.9

77.6

0.53

209

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

8.61

3.26

1.0

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

201

1582

1.33

3.20

1.8

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

168

1287

1.36

3.20

1.7

1.6

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

130

2.10

3.20

2.2

1.7

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

6.40

3.19

1.3

2.5

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

193

1.89

3.18

10.7

6.1

iu/ml

492.4

401.3

—

(3000991) Gas panel - Venous blood

101

712

1.46

3.10

9.7

9.5

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

308

1.69

3.06

3.4

2.7

g/l

7.7

7.3

0.77

241

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

308

1.69

3.06

3.4

2.7

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

308

1.69

3.06

3.4

2.7

g/l

3.6

3.7

0.16

228

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

147

2.00

3.02

1.2

1.4

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

3.02

2.97

1.2

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

265

1.73

2.96

5.5

3.0

g/l

0.5

1.4

1.13

240

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

289

1.69

2.92

3.5

2.8

g/l

3.1

0.06

233

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

2.85

2.92

1.4

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

2.85

2.92

1.4

—

(3026493) Urate [Moles/volume] in Serum or Plasma

280

2330

1.27

2.92

2.7

2.6

umol/l

4744.0

7017.2

0.38

244

2036

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

5.41

2.87

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

5.41

2.87

1.1

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

851

8966

0.79

2.83

4.3

4.2

mmol/l

1.4

1.5

5.36

765

8256

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

137

1.99

2.82

2.0

1.5

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

238

1950

1.28

2.81

1.3

u/ml

0.8

1.8

2.22

509

(40761535) Cells panel - Urine sediment

693

1.44

2.80

5.9

3.2

—

(3052592) Norovirus Ag [Presence] in Stool

4.47

2.80

1.1

1.5

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

502

1.51

2.77

2.6

3.3

pmol/l

4.4

4.6

0.83

438

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

703

1.43

2.77

2.4

ug/l

5.6

7.2

0.56

626

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

2.88

2.75

1.0

iu/ml

128.7

231.8

0.74

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

198

1589

1.30

2.74

2.9

3.0

mmol/l

2.5

2.4

1.32

179

1407

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

5.02

2.73

1.0

1.4

—

(3045424) Erythrocytes [Presence] in Urine

153

1.92

2.72

1.4

1.3

—

(3016330) Potassium [Moles/time] in 24 hour Urine

6.03

2.70

1.3

1.4

—

(3039443) Prostate specific Ag panel - Serum or Plasma

202

0.34

2.67

1.3

1.7

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

178

1.82

2.57

1.7

1.4

—

(3006576) Bicarbonate [Moles/volume] in Blood

3.62

2.57

11.9

7.8

mmol/l

31.5

25.6

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

822

8661

0.81

2.48

4.0

3.8

mmol/l

1.4

1.3

2.45

735

7941

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

878

9185

0.80

2.47

4.7

mmol/l

2.7

2.8

0.69

791

8454

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

123

1.97

2.46

2.1

1.6

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

152

1.86

2.44

1.2

1.1

—

(36660697) Celiac disease serology panel - Serum

686

1.40

2.44

1.2

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

110

2.02

2.42

1.3

1.2

nmol/l

0.5

0.6

0.31

102

(3051593) INR in Capillary blood by Coagulation assay

3.35

2.39

6.6

26.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

139

1.89

2.38

1.2

1.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

6.27

2.37

1.2

1.4

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

6.27

2.37

1.8

1.5

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

6.27

2.37

2.6

4.0

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

6.27

2.37

2.4

1.6

umol/l

44.0

32.0

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

283

1.61

2.37

1.7

1.9

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

3.65

2.36

1.0

—

(3024263) Appearance of Synovial fluid

2.63

2.36

1.3

1.6

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

2.16

2.35

1.6

1.3

—

(3012441) Differential panel - Pleural fluid

2.06

2.32

1.3

—

(1761868) Lipid panel - Serum or Plasma

291

3368

0.82

2.32

3.3

2.7

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

2.87

2.31

7.0

6.0

mg/l

59.6

72.2

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

239

1.65

2.28

1.5

1.3

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1004

9702

1.33

2.28

14.3

10.0

u/l

26.3

26.8

0.40

975

9364

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.50

2.27

1.3

1.2

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

202

1.70

2.23

2.1

1.5

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

2.35

2.22

1.3

1.2

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

5.57

2.21

1.0

1.1

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

2.79

2.20

4.0

3.5

u/l

176.9

202.3

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

3.35

2.18

1.0

1.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

982

0.70

2.18

2.1

2.0

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

165

0.36

2.16

1.5

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

388

1.49

2.15

6.5

4.4

mmol/l

25.8

24.8

1.13

366

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

3.02

2.15

1.1

1.0

miu/ml

1007.1

1628.2

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

102

1.98

2.11

1.4

2.2

mg/l

17.9

20.5

—

(3052851) Hemolysis interference index of Serum or Plasma

261

1.59

2.09

4.9

3.2

—

(4198724)

2.92

2.07

1.9

1.6

—

(4212803)

5.02

2.07

1.2

1.0

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

103

1.96

2.06

1.3

1.2

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

286

1.56

2.06

3.5

2.7

g/l

9.3

10.8

1.26

250

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

343

1.51

2.05

2.4

1.9

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

4.02

2.04

4.0

3.6

—

(3005033) Fetal Nuchal fold Thickness US

160

0.37

2.03

1.3

1.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

161

0.37

2.02

1.3

1.4

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

184

1520

1.25

2.02

1.3

iu/ml

18.4

35.7

2.91

476

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

2.06

2.02

3.6

4.3

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

2.02

2.01

1.2

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

1.98

2.01

1.3

1.2

nmol/l

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

163

1.74

1.99

1.7

1.4

u/ml

107.0

129.1

0.41

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

866

9025

0.82

1.99

4.3

mmol/l

4.6

4.7

2.27

789

8357

(3012516) Albumin [Mass/volume] in Urine

293

2547

1.20

1.97

2.9

3.3

mg/l

1333.7

222.7

1.44

193

1647

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

2.37

1.95

2.6

1.7

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

2.37

1.95

2.6

1.7

—

(3001019) Free T4 and TSH panel - Serum or Plasma

483

0.61

1.94

1.6

1.7

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

858

0.71

1.93

1.5

1.4

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

2.58

1.92

1.0

1.2

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

2.26

1.91

1.0

1.2

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

316

1.51

1.91

2.0

1.8

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

2.66

1.86

1.0

1.1

84.4

96.7

—

(4015189)

2.87

1.86

5.6

2.3

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

385

1.45

1.84

1.4

iu/l

26.2

26.9

0.05

333

(3020682) Albumin/Creatinine [Ratio] in Urine

305

2678

1.19

1.83

3.9

4.0

mg/mmol

8.6

8.3

0.06

194

1734

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

4.18

1.82

1.0

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.18

1.82

1.4

1.1

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

4.18

1.82

1.0

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

882

0.72

1.81

1.9

—

(3004775) Volume in Urine collected for unspecified duration

2.07

1.81

2.5

2.4

744.3

665.7

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

2.45

1.75

1.0

1.2

—

23.6

—

(3042631) Mycobacterium sp identified in Specimen

132

1.76

1.74

2.3

2.8

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

621

5791

1.16

1.73

3.4

3.0

—

(3048879) Bone marrow aspiration report

2.93

1.72

2.0

2.2

—

(3008536) Aspergillus sp Ab [Presence] in Serum

2.93

1.72

3.3

1.3

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

357

3193

1.17

1.71

4.9

ug/l

2.7

0.01

323

2862

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

1.89

1.71

2.6

2.5

—

(3006653) Thiamine [Moles/volume] in Blood

2.30

1.71

1.0

1.4

nmol/l

138.7

154.0

0.48

(3050129) First trimester maternal screen panel - Serum or Plasma

215

0.46

1.70

1.8

1.5

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

2.39

1.68

1.1

1.0

—

(3009508) Creatinine [Moles/volume] in Urine

310

2746

1.18

1.67

3.0

3.2

mmol/l

6.9

7.8

3.23

252

2311

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

3.17

1.66

1.2

1.4

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

161

1912

0.82

1.62

3.1

3.0

ug/l

0.8

0.7

0.34

114

1257

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

3.58

1.61

4.4

3.4

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

3.01

1.58

1.8

1.0

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

2.70

1.58

1.6

1.3

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

1.86

1.56

1.1

—

(3034426) Prothrombin time (PT)

2.43

1.54

1.1

1.5

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

130

1.71

1.53

1.2

u/ml

1.6

3.9

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

1.84

1.52

2.4

1.8

—

(4306422)

123

1.72

1.51

1.0

1.2

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

1.87

1.50

2.4

1.9

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

2.87

1.50

1.0

3.0

mmol/l

1.2

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

2.18

1.40

5.8

7.4

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

158

1.60

1.38

2.3

1.6

—

(3025941) Bacteria identified in Stool by Culture

488

1.33

1.36

1.4

1.2

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

358

1.39

1.36

1.1

—

2.3

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

2.95

1.36

1.0

1.1

—

(3014271) Vancomycin [Susceptibility]

2.14

1.34

3.7

2.3

—

(3047189) Immunofixation for 24 hour Urine

2.15

1.34

3.0

1.6

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1.98

1.33

2.6

1.6

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

152

1.59

1.32

1.2

1.1

—

11.4

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

2.10

1.30

1.2

1.3

—

(40768793) Breast Pathology biopsy report

205

0.53

1.28

1.2

1.3

—

(40758292) HTLV I+II Ab panel - Serum

2.79

1.28

1.2

1.3

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

2.01

1.27

1.1

1.0

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.29

1.27

1.0

1.3

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

138

1.61

1.27

1.1

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

245

1.44

1.24

4.0

2.8

g/l

35.9

37.8

0.87

216

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

139

1.59

1.23

1.1

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

237

1.45

1.23

1.4

u/l

8.7

9.3

0.13

195

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

147

1.58

1.23

1.4

1.2

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

1.78

1.23

3.6

63.2

52.1

—

(3000492) Spirometry study

870

0.78

1.21

1.5

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

2.64

1.21

1.4

1.3

—

(40768443) Skin Pathology biopsy report

375

1.35

1.21

1.6

1.2

—

(4010399)

615

1.27

1.19

1.5

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

214

1.46

1.19

1.8

1.7

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

2.11

1.18

4.5

4.4

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

2.01

1.16

2.5

1.7

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

2.01

1.16

2.5

1.7

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

2.01

1.16

2.5

1.7

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

2.01

1.16

2.5

1.7

—

(44790047)

102

1.68

1.16

1.6

1.7

—

(44806118)

102

1.68

1.16

1.6

1.7

—

(44790049)

102

1.68

1.16

1.6

1.7

—

(44790048)

102

1.68

1.16

1.6

1.7

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

2.51

1.15

1.2

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

2.01

1.12

2.9

1.9

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

2.01

1.12

2.9

1.9

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

135

1.57

1.12

1.2

—

(3005322) IgE [Units/volume] in Serum or Plasma

567

1.27

1.11

1.6

1.3

u/ml

112.5

180.0

1.43

521

(3035880) pH of Pleural fluid

1.97

1.11

1.1

1.2

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

2.39

1.09

1.0

1.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

1.96

1.09

3.0

1.8

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

128

1.57

1.09

1.1

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

166

1449

1.17

1.08

1.3

u/ml

3.4

11.2

2.27

571

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

2.19

1.08

1.1

—

(40758558) Short blood count panel - Blood

246

2213

1.14

1.07

9.5

6.6

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

1.77

1.07

1.0

1.1

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

262

1.39

1.06

1.2

1.1

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

192

0.57

1.06

1.3

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

192

0.57

1.06

1.3

1.4

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

653

1.24

1.05

3.2

3.8

ng/l

81.6

85.0

0.13

573

(3007566) Smooth muscle Ab [Titer] in Serum

254

1.39

1.05

1.1

1.2

titre

61.7

95.0

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

191

0.57

1.04

1.3

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

191

0.57

1.04

1.3

1.4

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

691

1.23

1.04

2.9

2.6

ml/min/173m2

67.9

66.1

0.13

275

(3021387) Prolactin [Units/volume] in Serum or Plasma

298

1.35

1.03

1.5

1.6

mu/l

351.3

292.4

0.53

266

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

179

1.46

1.03

1.2

—

8.6

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

202

0.59

1.02

1.3

1.5

—

(3036782) Glucose [Moles/volume] in Pleural fluid

1.70

1.01

1.2

1.3

mmol/l

5.8

6.3

0.37

(3017704) Immunofixation for Urine

1.88

1.00

1.2

1.7

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

2.01

1.00

1.1

2.7

—

55726.6

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

823

1.21

1.00

2.6

2.3

u/l

34.4

38.3

0.25

707

(3036048) Francisella tularensis Ab [Titer] in Serum

2.18

0.98

1.0

1.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

2.18

0.98

1.0

1.1

—

(3037121) Protein [Mass/volume] in Urine

319

1.33

0.97

3.1

3.6

g/l

0.6

0.2

0.44

128

(3037692) Legionella sp identified in Specimen by Organism specific culture

1.95

0.97

1.1

1.8

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

1.81

0.96

5.0

3.6

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

329

0.69

0.96

1.4

1.5

—

(3028707) Methadone [Presence] in Urine by Screen method

141

1.50

0.95

3.0

2.7

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

133

1.51

0.94

1.3

u/ml

2.7

5.7

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

1.74

0.92

1.2

1.3

—

(3023383) Lactate [Moles/volume] in Pleural fluid

2.15

0.91

1.0

1.3

mmol/l

5.8

3.6

—

(21494434) Karyotype in Bone marrow

1.64

0.91

1.0

1.3

—

(4268621)

1.60

0.91

2.4

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

177

1.42

0.89

1.6

1.2

u/ml

260.3

257.3

0.02

106

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

1.91

0.88

1.5

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

1.91

0.88

1.5

1.4

—

(21494890) Protein electrophoresis panel - 24 hour Urine

1.62

0.87

2.8

1.9

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

423

1.27

0.87

2.4

—

(3000330) Specific gravity of Urine by Test strip

441

1.26

0.87

5.2

3.6

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

144

1.47

0.87

1.1

—

(3008898) HLA-B27 [Presence]

334

1.30

0.87

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

256

1.34

0.85

1.1

—

(44806420)

1.94

0.84

3.8

2.5

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

1.94

0.84

5.8

2.8

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

1.78

0.84

2.9

3.3

u/ml

862.0

1368.6

—

(3016750) Collection duration of Urine

1.76

0.83

2.0

2.3

min

546.0

493.0

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

154

1.44

0.83

6.0

3.4

—

(3009542) Hematocrit [Volume Fraction] of Blood

868

8458

1.12

0.82

25.7

14.4

39.0

40.1

2.25

500

6167

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

189

1.38

0.81

1.6

1.2

—

(3051611) Lipemic interference index of Serum or Plasma

1.58

0.81

6.4

3.6

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

1.58

0.81

1.1

1.0

—

(3017569) Oxygen content in Arterial blood

1.71

0.80

2.8

3.6

—

(42529406) Shigella sp [Presence] in Stool by Culture

259

1.32

0.80

1.1

1.2

—

(1761482) Bacteria [#/volume] in Urine by Culture

233

1.34

0.80

7.1

4.7

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

1.73

0.79

1.3

1.7

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1111

0.85

0.79

4.8

4.3

31.9

31.7

0.06

731

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

897

8770

1.11

0.75

4.6

4.4

mmol/l

5.9

0.13

818

7986

(4035726)

776

1.17

0.73

1.3

1.4

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

1.62

0.72

1.2

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

1.62

0.72

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

1.62

0.72

1.2

1.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

1.75

0.71

1.0

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

256

1.30

0.70

1.2

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

760

1.17

0.70

1.5

1.6

—

(3000475) Leukocytes [#/volume] in Synovial fluid

212

1.33

0.70

1.3

1.7

e6/l

17676.0

13701.7

0.17

158

(40768804) Tissue Pathology biopsy report

379

3574

1.09

0.70

1.9

2.1

—

(3000093) Morphology [Interpretation] in Blood Narrative

1.56

0.68

1.0

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

1.60

0.68

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

1.60

0.68

1.2

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

1.60

0.68

1.2

1.1

—

(4146454)

1.50

0.67

3.1

2.7

—

(3044941) Cell count panel - Synovial fluid

137

1.39

0.65

1.2

1.4

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.73

0.64

1.2

1.1

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

1.54

0.59

1.1

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

1.54

0.59

1.1

1.0

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

0.00

0.59

0.0

6.0

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.00

0.59

0.0

3.0

—

(4133840)

0.00

0.59

0.0

1.1

—

(3045142) Bone marrow Pathology biopsy report

1.45

0.59

1.3

1.4

—

(3014051) Protein [Presence] in Urine by Test strip

193

1.30

0.58

2.3

2.1

—

(3021788) Differential panel - Synovial fluid

158

1.34

0.57

1.4

1.6

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

411

1.20

0.57

2.3

2.6

u/ml

32.3

55.1

0.78

396

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

1.49

0.57

2.5

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

1.49

0.57

2.5

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

1.49

0.57

2.5

1.6

—

(4281824)

0.58

0.56

1.0

1.2

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

1.54

0.55

1.3

1.6

umol/l

10.7

12.3

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

385

1.20

0.55

1.5

1.8

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

330

1.22

0.55

1.5

1.7

—

(3007461) Platelets [#/volume] in Blood

1030

10186

1.14

0.55

36.9

19.8

e9/l

257.7

248.9

3.92

1021

9922

(3024731) MCV [Entitic volume]

1030

10188

1.13

0.53

36.8

19.7

90.7

90.9

0.73

1024

10034

(3051651) Icteric interference index of Serum or Plasma

1.48

0.53

8.1

3.7

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

1.49

0.53

2.0

2.1

—

(3035941) MCH [Entitic mass]

1030

10190

1.13

0.52

36.8

19.7

30.1

30.3

4.28

1024

10035

(3026361) Erythrocytes [#/volume] in Blood

1030

10191

1.13

0.52

36.9

19.7

e12/l

4.4

4.5

10.16

1021

9896

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

1.47

0.50

1.2

u/ml

0.5

0.9

—

(3000963) Hemoglobin [Mass/volume] in Blood

1030

10194

1.13

0.50

37.1

19.9

g/l

131.5

136.3

19.31

1024

10037

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

456

1.17

0.49

1.1

1.0

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

244

1.24

0.48

1.2

1.4

—

(3023199) Leukocytes [#/volume] in Pleural fluid

102

1.38

0.47

1.6

1.3

e6/l

2213.8

1715.1

—

(3022145) Colonoscopy Study observation

109

989

1.11

0.47

1.3

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

111

1.36

0.46

1.5

1.4

nmol/l

0.3

0.4

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

1.39

0.46

1.5

1.2

e6/l

248541.9

47009.9

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

237

1.23

0.45

2.6

2.4

ug/min

58.5

100.7

0.74

148

(3048929) Epstein Barr virus Ab [Presence] in Serum

292

1.21

0.45

1.5

1.2

—

(3010813) Leukocytes [#/volume] in Blood

1029

10192

1.12

0.44

37.0

19.8

e9/l

6.9

6.7

2.07

1019

9897

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

1.62

0.43

1.0

1.2

g/l

0.4

0.3

—

(3005570) Glucose [Moles/volume] in Urine

1.38

0.42

4.0

2.2

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

194

1.24

0.42

1.7

1.4

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

1.38

0.41

1.3

1.5

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

0.00

0.41

0.0

1.1

—

1.9

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

0.00

0.40

0.0

1.1

—

207.8

—

(3028433) Virus identified in Specimen by Culture

1.47

0.40

1.2

1.6

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

1.47

0.40

1.6

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.40

0.0

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

292

0.82

0.40

1.6

1.5

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

1.34

0.39

1.6

2.2

umol/l

3.6

6.8

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.43

0.39

1.2

1.1

—

(3035285) Chloride [Moles/volume] in Venous blood

115

1.31

0.39

2.3

2.4

mmol/l

103.7

105.4

0.51

115

(3041354) Potassium [Moles/volume] in Venous blood

115

1.31

0.39

2.3

2.4

mmol/l

4.3

4.0

1.31

115

(3019225) pH of Specimen

863

1.10

0.35

3.6

4.1

—

(3024928) Oxygen saturation in Venous blood

190

1.21

0.35

4.0

3.1

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

876

0.91

0.34

2.6

4.4

ug/l

3.8

26.7

1.68

724

(3011288) Drugs identified in Urine by Screen method

218

1.20

0.34

2.5

2.9

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

1.31

0.33

1.2

1.7

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

1.31

0.33

1.2

1.7

—

(3034770) Mitochondria Ab [Titer] in Serum

266

1.17

0.32

1.1

1.2

—

586.3

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

268

2570

1.06

0.32

4.6

4.2

20.8

21.1

0.14

140

1226

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

1.35

0.31

1.3

1.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

601

1.10

0.30

1.2

iu/ml

130.0

144.5

0.09

249

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

1.25

0.29

1.7

1.1

u/l

49.0

17.4

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

241

1.17

0.29

1.4

ug/g

308.7

291.7

0.18

139

(3039162) Centromere protein B Ab [Units/volume] in Serum

112

1.25

0.28

1.1

1.2

—

28.9

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

112

1.25

0.28

2.4

—

(40768806) Pleura Pathology biopsy report

103

1.27

0.28

1.5

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

106

1131

0.93

0.27

2.0

1.8

1.5

0.36

997

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

1.25

0.27

1.1

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

1.25

0.27

1.0

1.2

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

1.23

0.27

1.3

1.2

u/l

16.8

11.3

—

(3011648) Oxygen content in Venous blood

1.20

0.26

1.9

1.7

9.8

10.0

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

139

1317

1.06

0.26

1.6

1.4

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

181

0.83

0.25

1.3

1.2

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

113

1065

1.07

0.25

9.2

6.4

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

1.20

0.25

1.0

1.4

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

1.19

0.24

2.7

1.9

—

(3004616) Nuclear Ab [Presence] in Serum

106

1.23

0.23

1.2

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

136

0.81

0.23

1.0

1.1

u/ml

0.5

2.9

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

257

1.13

0.22

2.5

2.1

—

(3002256) Pathology report gross observation

127

1208

1.06

0.22

1.3

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

849

8572

0.96

0.22

23.7

12.5

ml/min/173m2

87.1

82.0

7.39

739

7047

(3017446) Testosterone [Moles/volume] in Serum or Plasma

750

1.07

0.21

2.0

2.2

nmol/l

12.3

13.2

0.40

671

(3032868) Hemoglobin electrophoresis panel in Blood

0.00

0.21

0.0

1.1

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

3.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

102

0.78

0.21

2.4

1.3

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.00

0.21

0.0

1.2

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

278

1.12

0.20

1.3

1.4

—

(3051101) Glucose [Moles/volume] in Cord blood

0.00

0.20

0.0

5.6

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

0.00

0.20

0.0

1.2

—

1.8

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

1.20

0.19

1.5

7.7

u/ml

—

75.0

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

491

1.08

0.19

1.6

1.9

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

1.21

0.18

1.7

1.1

u/l

92.3

83.8

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

839

8320

1.03

0.17

5.8

5.5

mmol/mol

39.7

0.07

772

7703

(44813793)

1.13

0.17

1.0

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

0.75

0.17

1.2

1.0

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

0.72

0.17

1.2

1.4

—

72.5

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

140

1.14

0.15

1.3

1.2

—

(3045788) Cell count panel - Pleural fluid

1.08

0.14

1.7

1.3

—

(3044927) Protein electrophoresis panel - Urine

1.18

0.14

1.3

1.2

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

102

979

1.05

0.14

1.6

1.7

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

246

2403

1.03

0.14

1.7

mmol/l

1.5

1.4

0.71

199

2014

(3023420) DNA double strand Ab [Units/volume] in Serum

0.78

0.14

2.6

1.4

—

32.7

—

(40768800) Prostate Pathology biopsy report

202

0.89

0.14

1.3

1.2

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

1.17

0.13

2.2

1.5

ug/l

12.6

19.7

2.11

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

107

0.84

0.13

1.6

1.5

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

158

1537

1.03

0.12

1.8

1.5

—

(3003327) Ova and parasites identified in Stool by Light microscopy

292

0.92

0.12

1.9

1.7

—

(3003740) Influenza virus B Ag [Presence] in Specimen

167

0.90

0.10

1.5

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

1.09

0.09

1.8

1.3

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

281

1.07

0.09

1.1

1.3

miu/ml

408.1

227.1

—

136

(3045683) HLA typing for celiac disease panel - Blood or Tissue

1.06

0.09

1.0

—

(3048689) Calprotectin [Mass/mass] in Stool

110

1071

1.03

0.09

1.9

2.3

ug/g

152.0

122.9

0.46

849

(3016879) Cocaine [Presence] in Urine

308

0.94

0.08

2.6

2.0

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

0.82

0.08

1.0

1.2

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

205

1.07

0.08

2.4

1.8

pmol/l

206.7

223.2

0.21

191

(3032773) Endomysium IgG Ab [Titer] in Serum

0.85

0.07

1.0

1.1

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

1.12

0.07

1.0

1.3

e6/l

84304.0

120659.0

—

(3023511) Choriogonadotropin [Units/volume] in Urine

138

1.09

0.06

1.8

1.3

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

233

0.94

0.06

1.4

1.2

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

170

0.94

0.04

1.3

1.2

—

(4034850)

261

0.96

0.04

7.1

8.8

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

159

0.94

0.03

1.0

1.1

u/ml

0.6

2.2

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

330

0.97

0.03

1.7

1.8

—

(3025130) Human papilloma virus identified in Specimen

112

1.07

0.03

2.3

1.7

—

(4094501)

241

1.04

0.02

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

168

0.95

0.02

1.4

1.1

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

570

1.02

0.02

1.1

1.2

—

(1002224) Polysomnography panel

398

0.98

0.01

1.1

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

193

1.04

0.01

1.6

—

(3000764) Benzodiazepines [Presence] in Urine

324

1.02

0.00

2.4

1.9

—

(3027008) Opiates [Presence] in Urine

326

0.98

0.00

2.3

1.9

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

144

0.97

0.00

1.0

1.1

u/ml

2.6

7.1

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

112

0.98

0.00

2.4

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

112

0.98

0.00

2.4

1.4

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

132

0.98

0.00

2.0

1.8

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

1.01

0.00

1.3

1.6

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

111

0.99

0.00

2.4

1.5

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

149

1.01

0.00

1.5

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

231

1.00

0.00

1.3

1.8

iu/l

9.0

5.0

0.35

(3003694) ABO and Rh group [Type] in Blood

253

2531

1.00

0.00

1.5

1.4

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

123

0.98

0.00

1.1

1.0

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

283

0.99

0.00

1.5

1.3

—

(3028300) Cannabinoids [Presence] in Urine

327

1.01

0.00

2.4

1.9

—

(3027944) Amphetamines [Presence] in Urine

325

0.98

0.00

2.4

1.8

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

135

1.04

0.00

1.0

u/ml

1.2

2.9

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

1.7

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

0.00

0.0

5.1

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

0.0

1.1

—

(40758358) Immune stain study

0.00

0.0

1.0

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

0.93

0.00

1.0

mg/l

276.1

285.3

—

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

0.00

0.0

1.6

—

559.6

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

1.01

0.00

1.6

1.4

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.0

1.7

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

110

1.00

0.00

2.4

1.5

—

(40768795) Lymph node Pathology biopsy report

0.96

0.00

1.1

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

0.00

0.0

3.0

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

0.00

0.0

1.1

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

110

1.00

0.00

2.4

1.5

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

0.00

0.0

3.4

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.0

5.1

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

0.0

1.0

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3013762) Body weight Measured

0.00

0.0

1.4

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

0.00

0.0

2.4

—

70.1

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.0

1.1

—

(3011048) Pyruvate [Moles/volume] in Blood

0.00

0.0

1.1

—

90.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

0.89

0.00

1.3

1.2

—

(3011544) Albumin [Mass/volume] in Pleural fluid

0.00

0.0

1.0

—

17.4

—

(3042517) Benzodiazepines panel - Urine

0.00

0.0

1.2

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

110

1.00

0.00

2.4

1.4

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

0.00

0.0

2.7

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.0

1.6

—

2.2

—

(3035320) C reactive protein [Mass/volume] in Body fluid

0.97

0.00

1.8

2.2

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

450

1.00

0.00

1.2

1.3

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint G6_SPINOTH and mortality.

Females

Parameter	HR [95% CI]	p-value
G6_SPINOTH	2.357 [2.03, 2.73]	< 0.001
Birth year	0.994 [0.99, 1.0]	0.146

During the follow-up period (1.1.1998 — 31.12.2019), 600 out of 2883 females with G6_SPINOTH died.

Males

Parameter	HR [95% CI]	p-value
G6_SPINOTH	2.303 [2.02, 2.62]	< 0.001
Birth year	0.988 [0.98, 1.0]	0.014

During the follow-up period (1.1.1998 — 31.12.2019), 902 out of 3328 males with G6_SPINOTH died.

Mortality risk

Mortality risk for people of age

years, who have G6_SPINOTH.

N-year risk	Females	Males
1	0.185%	0.515%
5	1.342%	2.816%
10	3.579%	7.176%
15	6.771%	13.09%
20	11.097%	21.615%

Relationships between endpoints

↥

Index endpoint: G6_SPINOTH – Other diseases of spinal cord

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other diseases of spinal cord

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints